GB1387929A - Polymerization products containing amino groups and a method of producing such products - Google Patents
Polymerization products containing amino groups and a method of producing such productsInfo
- Publication number
- GB1387929A GB1387929A GB2610672A GB2610672A GB1387929A GB 1387929 A GB1387929 A GB 1387929A GB 2610672 A GB2610672 A GB 2610672A GB 2610672 A GB2610672 A GB 2610672A GB 1387929 A GB1387929 A GB 1387929A
- Authority
- GB
- United Kingdom
- Prior art keywords
- residues
- water
- products
- amino groups
- bridges
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000003277 amino group Chemical group 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000006116 polymerization reaction Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 230000008961 swelling Effects 0.000 abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 235000012000 cholesterol Nutrition 0.000 abstract 1
- 150000004985 diamines Chemical class 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 150000003840 hydrochlorides Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 239000003456 ion exchange resin Substances 0.000 abstract 1
- 229920003303 ion-exchange polymer Polymers 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
- C08G59/50—Amines
- C08G59/5006—Amines aliphatic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE722071A SE360367B (enExample) | 1971-06-04 | 1971-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1387929A true GB1387929A (en) | 1975-03-19 |
Family
ID=20270765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2610672A Expired GB1387929A (en) | 1971-06-04 | 1972-06-05 | Polymerization products containing amino groups and a method of producing such products |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2227123A1 (enExample) |
| FR (1) | FR2140204B1 (enExample) |
| GB (1) | GB1387929A (enExample) |
| SE (1) | SE360367B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877775A (en) * | 1986-06-16 | 1989-10-31 | E. I. Du Pont De Nemours And Company | Polymeric aminosaccharides as antihypercholesterolemic agents |
-
1971
- 1971-06-04 SE SE722071A patent/SE360367B/xx unknown
-
1972
- 1972-06-02 FR FR7219932A patent/FR2140204B1/fr not_active Expired
- 1972-06-03 DE DE19722227123 patent/DE2227123A1/de active Pending
- 1972-06-05 GB GB2610672A patent/GB1387929A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2140204B1 (enExample) | 1975-10-31 |
| DE2227123A1 (de) | 1973-01-04 |
| FR2140204A1 (enExample) | 1973-01-12 |
| SE360367B (enExample) | 1973-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3980770A (en) | Polymerization products containing amino groups useful in serum cholesterol level control | |
| CA1218077A (en) | Resinate of a substituted carboxylic acid, the preparation and use thereof, and pharmaceutical compositions containing it | |
| EP0560816B1 (en) | New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof | |
| ES8800041A1 (es) | Un procedimiento para la produccion de una composicion farmaceutica de liberacion controlada de unidades individuales | |
| GB929391A (en) | Therapeutic compositions comprising polymeric amines | |
| AU4386097A (en) | Process for the polymerization of alpha-olefins, a catalyst used in the polymerization and its preparation | |
| DK525986D0 (da) | Farmaceutisk pulver- eller tabletpraeparat indeholdende ibuprofen | |
| US3506642A (en) | Stable orally active heparinoid complexes | |
| EP0175667A2 (en) | Macrophage-activating composition and a process for its manufacture | |
| US2611730A (en) | Medical preparation for reducing the body level of sodium | |
| WO1992004013A1 (en) | Multiparticulate sustained release matrix system | |
| FR2772382B1 (fr) | Derives de dextrane, leur procede de preparation et leurs applications comme medicaments a action biologique specifique | |
| HUT52398A (en) | Badly soluble pharmaceutical compositions with polymer vehicle | |
| DE2963990D1 (en) | Analgesic tablet and process for its preparation | |
| US4439419A (en) | Method of treating gastric hyperacidity in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance as epichlorhydrin | |
| GB2036048A (en) | Polymer compounds, process for their preparation and arteriosclerosis treating agents containing them | |
| EP0539627B1 (en) | A process for the purification of commercial carrageenins | |
| GB1387929A (en) | Polymerization products containing amino groups and a method of producing such products | |
| CA1094452A (en) | Solution and substance for the preparation thereof | |
| GB1357737A (en) | Sustained release pharmaceutical compositions | |
| GB1385550A (en) | Polymerisation products containing amino groups and a method of producing such products | |
| US3214341A (en) | Prolonged action medicament | |
| JPH0379602A (ja) | 免疫刺激・抗増殖作用を有する多糖類、その製造方法及びこの物質を含有した薬剤 | |
| US3130126A (en) | Oral pharmaceutical products prepared with carboxymethyl benzyl dextran having a low carboxymethyl d. s. of 0.15 | |
| US3130125A (en) | Preparation of medicated benzyl dextran gradual release therapeutic products containing up to five percent benzyl alcohol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |